With the results of a recent trial, Abbott is seeking an expanded indication from the FDA for its CardioMEMS device, intended to prevent hospitalizations in patients with heart failure. It’s also hoping to win over national coverage from CMS.
The company offers a remote patient monitoring platform that enables clinicians to not only monitor patients at home but also provide personalized feedback via texts and video visits. The platform will be deployed at LifePoint Health facilities and used to deliver remote care to more than 100,000 patients.
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
Biofourmis, a Boston-based digital health startup, recently received breakthrough designation for its digital therapeutic to help ensure heart failure patients receive medications that are consistent with clinical evidence at the right dose.
The drugmaker struck a collaboration agreement with Mass General to use its platform for heart failure and asthma management. The health system plans to launch two pilots of the digital health platform.
Heart failure patients reported reduced depression symptoms and better self-care after receiving behavioral therapy through telehealth services, according to a small study by AbleTo and Humana.
Biofourmis's CEO boldly declared the company will become a unicorn and this acquisition is expected to give the startup access to more raw data as it expands its analytics platforms and brings Biovotion's Everion wearable armband inhouse.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
Houston-based CorInnova won the medical device track for the Pitch Perfect contest at the MedCity INVEST conference in Chicago.
WhiteSwell is pitching a technology to better treat acute decompensated heart failure by finding an alternative route to decongest the fluid back-up caused by the heart's inability to pump effectively.
The company was founded last year and has developed technology that analyzes data from a combination of clinical and commercial devices to monitor and track the health status of patients at home.
A new study in the Journal of the American Heart Association found there was not an association between a hospital's degree of EHR implementation and improved quality of care and outcomes for heart failure patients.
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
The study out of Vanderbilt University Medical Center found 14 percent of individuals with genetic variants impacting the kidney had kidney transplants and 10 percent with another variant had liver transplants. These transplants could have been avoided had the underlying genetic cause been disclosed.
Massachusetts General Hospital is working with Jana Care to conduct a study on the company's heart failure management mobile app, called Heart Habits.
The device could be the next evolution in assistive technology, helping manage congestive heart failure more safely.
Neuromodulation is gaining ground as a therapy for reducing pain, but no one has yet harnessed it within the cardiology arena, putting the company in a unique position if the Barostim gains FDA approval and commercial success.
scPharmaceuticals has raised $3.6 million in what looks to be a bridge financing round for its drug/device combo that could replace IV use in treating heart failure and infections.